Lamanna Details Evolution of CLL Treatment Following Resistance
Nicole Lamanna, MD, discusses treatment options for patients with chronic lymphocytic leukemia who develop resistance to a prior treatment.
Source: onclive.com
Stay updated with breaking news from Double Refractory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nicole Lamanna, MD, discusses treatment options for patients with chronic lymphocytic leukemia who develop resistance to a prior treatment.
AFM13 in combination with NK cells shows very high overall and complete response rates in 41 heavily pre-treated CD30-positive Hodgkin lymphoma (HL) and...